
Getinge Introduced Volista VisioNIR, Projected To Disrupt The Surgical Lighting Industry
By Indu Tyagi Ketan , 17 November, 2022
Getinge introduced Volista VisioNIR, a revolutionary surgical light solution, in October 2021. The product was aimed to enable surgical professionals to continue using the operating light during open procedures when employing NIR fluorescence imaging equipment. To find structures that need to be removed, such as sentinel lymph nodes, cancerous cells, and luminal calcifications, and to avoid other systems that might result in acute or long-term morbidity, such as nerves, blood vessels, ducts, lymphatics, and healthy glands, NIR (near-infrared) fluorescence imaging was developed.
When using fluorescence-guided surgery, the new Volista VisioNIR function aids in guiding surgeons and securing their actions with more excellent hand-eye synchronization. No longer is it necessary to alternate between on and off lights. Lights remaining on during the entire treatment ensures an unbroken workflow where staff can devote all their attention to the patient, saving time and resources.
It is anticipated that the product has the potential to upend the surgical light market. The use of adequate lighting is essential for accurate and efficient surgical performance for the best achievable patient outcome. The surgeon's headlight is the gold standard for intense, focused lighting. Still, it has several drawbacks, such as physical discomfort, encouragement of poor ergonomic posture, a lack of cleanliness, and a role in physician distraction during treatment. Headlights’ impact on surgery—a physically taxing activity already—may be the most harmful. An incorrect ergonomic position can eventually cause the surgeon to sustain a significant physical injury and experience chronic pain.
Additionally, the market has witnessed similar product introductions and innovations intended for similar concerns. For instance, Josh Mezrich, a transplant surgeon at the University of Wisconsin, created the MezLight in response to his and his colleagues' experiences with the need for more excellent lighting in the operating room.
GBD Disease Catagories

Latest News

The leaders in the global cloud infrastructure market, AWS and Microsoft, Azure, still dominate the sector with a market share of 31 percent and 20 percent, respectively, in 2025. While the competition is growing fiercer and cloud computing focused…

Driven by fast economic development and a rising need for electrification, India's energy consumption is expected to rise at an average annual rate of 6.3 percent from 2025 through 2027 (International Energy Agency, IEA). Mostly driven by a jump in…

Japan has made a remarkable amendment to its energy policy, indicating an increased emphasis on nuclear energy in 2025. It plans to achieve a 20% share of nuclear energy in electricity generation by 2040, a complete reversal from its post-Fukushima…

Energy Secretary Ed Miliband will visit China from March 17 to 19, 2025, to boost the United Kingdom’s (UK) renewable energy initiatives. This visit aims to revive the UK-China Energy Dialogue, excluding nuclear power, via clean and sustainable…

In 2025, the global semiconductor industry is set to boom as sales are projected to increase by 15 percent, reaching nearly USD 721 billion. This growth is prominent in both the technological region and the aiding toward the clean energy shift.
With…

Chief Strategy Officer
Latest News




